Actionable news
0
All posts from Actionable news
Actionable news in AKRX: Akorn, Inc.,

Analysts' Actions — Biogen, GoPro, L Brands, Time Warner and More

RATINGS CHANGES

Akorn (AKRX) was downgraded to underperform from buy at Bank of America/Merrill Lynch. $22 price target. The company is facing potential risks on several fronts, analysts said.

Biogen (BIIB) was upgraded to overweight from neutral at Piper Jaffray. $335 price target. The valuation is reasonable, given opportunities in Alzheimer's and SMA, Piper said.

BioMarin (BMRN) was downgraded to neutral from overweight at Piper Jaffray. $84 price...


More